Alphamab Oncology 康寧傑瑞生物製藥
Pay for financial year ended 2023-12-31
| Name | Last position |
Fees | Salary & benefits |
Bonus | Retire | Share- based |
Total | |
|---|---|---|---|---|---|---|---|---|
CNY '000 |
||||||||
Directors |
||||||||
| 1 | Guo, Zijian (1962) 郭子建 | INED | 378 | 378 | ||||
| 2 | Liu, Yang (1972) 劉陽 | ED | 2,559 | 290 | 124 | 2,973 | ||
| 3 | Wei, Kevin Cheng 蔚成 | INED | 340 | 56 | 396 | |||
| 4 | Wu, Dong (1969) 吳冬 | INED | 344 | 56 | 400 | |||
| 5 | Xu, Ting (1973) 徐霆 | Ch, CEO, Fdr | 6,548 | 214 | 115 | 6,877 | ||
| Total | 1,062 | 9,107 | 504 | 239 | 112 | 11,024 | ||
Main board pay history
Click on the year-end to see the pay details.
CNY'000
| Year-end | Fees | Salary & benefits |
Bonus | Retire | Share- based |
Total | |
|---|---|---|---|---|---|---|---|
| 2023-12-31 | 1,062 | 9,107 | 504 | 239 | 112 | 11,024 | Report |
| Total | 1,062 | 9,107 | 504 | 239 | 112 | 11,024 |
Want to see more years here? volunteer to be a Webb-site editor and add the data from annual reports!
Sign up for our free newsletter
Recommend Webb-site to a friend
Copyright & disclaimer, Privacy policy